Certified by Founder Lodge
ArsenalBio
United States - South San Francisco , CA
START UP
1 Disclosed Funding Rounds $220,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
ArsenalBio is a privately held, programmable cell therapy company focused on the realization of solid tumor cell therapy to defeat cancer. Our discovery engine comprises precise CRISPR-enable
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 09 ,2022 | Series B | $220,000,000 |
Sixth Street
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Adronite | $5,000,000 | (Feb 20, 2026)
SPRX | $31,000,000 | (Feb 20, 2026)
Vizzia | $35,300,400 | (Feb 20, 2026)
Altesa BioSciences, Inc. | $75,000,000 | (Feb 20, 2026)
NuCube Energy | $13,000,000 | (Feb 20, 2026)
